Copyright
©The Author(s) 2021.
World J Hepatol. Jan 27, 2022; 14(1): 180-194
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.180
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.180
Deficiency | Presentation | General biochemical abnormalities | Fatty acid metabolites | Gene | Newborn screen | Treatment |
OCTN2 | Hepatomegaly; Lethargy; Encephalopathy; Hypotonia | Raised transaminases; Hyperammonemia; Lactic acidosis | Low plasma acyl carnitine and free carnitine, high urine carnitine | SLC22A5 | Low free carnitine | Carnitine supplementation |
CPT-1 | Reye-like syndrome; Renal tubular acidosis | Raised transaminases; Acidosis; Hyperammonemia | High free carnitine, low long chain acyl carnitine | CPT-1A | Increased free carnitine | Avoid fasting; Uncooked cornstarch; Medium chain triglyceride supplements |
CACT | Coma; Cardiomyopathy; Apnoea; Seizures | Raised transaminases; Hyperammonemia; Elevated creatine phosphokinase | Low free carnitine, high long chain acyl carnitine, high urine dicarboxylic acid | SLC25A20 | Increased long chain acyl carnitine | High carbohydrate low long chain fat diet; Medium chain triglyceride supplements; Carnitine |
CPT-2 | Encephalopathy; Hypotonia; Myalgia; Myoglobinuria; Neuronal migration defects; Cardiomegaly; Nephromegaly | Raised transaminases; Hyperammonemia; Elevated creatine phosphokinase | Low free carnitine, high long chain acyl carnitine, high urine dicarboxylic acid | CPT-2 | High long chain acyl carnitine (C16, C16:1, C18, C18:1) | Intravenous glucose; Night-time feeds; High carbohydrate low long chain fat diet; Medium chain triglyceride supplements; Carnitine; Bezafibrate |
VLCAD | Hypertrophic cardiomyopathy; Encephalopathy; Exercise induced myolysis | Raised transaminases; Hyperammonemia; Elevated creatine phosphokinase; High lactate | Low free carnitine, High C12, C14:1, C16 acylcarnitines. | ACADVL | High C12, C14:1, C16 acylcarnitine | Night-time feeds; High carbohydrate low long chain fat diet; Medium chain triglyceride supplements; Bezafibrate; Triheptanoin |
MCAD | Vomiting; Lethargy; Encephalopathy | Hypoketotic hypoglycemia; Raised transaminases, ammonia, lactate, creatine phosphokinase, uric acid, blood urea nitrogen | High medium chain acyl carnitine; Free carnitine may be low or normal. Urine: Dicarboxylic acid, suberyl glycine, hexanoyl glycine | ACADM | High C6:0-, C8:0-, C10:0- and C10:1-acylcarnitines | Frequent feeding; Uncooked cornstarch |
SCAD1 | Hypotonia; Seizures; Failure to thrive; Behavioral disorders | Raised transaminases, ammonia, lactate, uric acid, blood urea nitrogen, mild acidosis | High C4 carnitine, ethymalonic acid in urine | ACADS | High C4 carnitine | Frequent feeding; Riboflavin; Carnitine |
LCHAD | Hypotonia; Hepatomegaly; Rhabdomyolysis; Retinitis pigmentosa; Peripheral neuropathy; HELLP syndrome in mothers | Raised transaminases, ammonia, lactate, creatine phosphokinase | Low free carnitine; High hydroxyacyl carnitine; Hydroxydicarboxylic acid in urine | HADHA | High long chain hydroxyacyl carnitine | Intravenous glucose; Night-time feeds; Uncooked cornstarch; Medium chain triglyceride supplement; Docosahexaenoic acid supplement; Triheptanoin |
- Citation: Ravindranath A, Sarma MS. Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects. World J Hepatol 2022; 14(1): 180-194
- URL: https://www.wjgnet.com/1948-5182/full/v14/i1/180.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i1.180